Computer-Aided and Machine Learning-Driven Drug Design

The computer-aided drug design research field comprises several different knowledge areas, and often, researchers are only familiar or experienced with a small fraction of them. Indeed, pharmaceutical industries and large academic groups rely on a broad range of professionals, including chemists, biologists, pharmacists, and computer scientists. In this sense, it is difficult to be an expert in every single CADD approach. Furthermore, there are well-established methods that are constantly revisited, and novel approaches are introduced, such as machine-learning based scoring functions for molecular docking. This book provides an organized update of the most commonly employed CADD techniques, as well as successful examples of actual applications to develop bioactive compounds/drug candidates. Also includes is a section of case studies that cover certain pharmacological/target classes, focusing on the applications of the previously described methods. This part will especially appeal to professionals who are not as interested in the theoretical aspects of CADD. This is an ideal book for students, researchers, and industry professionals in the fields of pharmacy, chemistry, biology, bioinformatics, computer sciences, and medicine who are seeking a go-to reference on drug design and medicinal chemistry.

Vinícius Gonçalves Maltarollo is a Professor of Medicinal Chemistry at the Faculty of Pharmacy, Federal University of Minas Gerais in Brazil since 2016. Before that, he taught several other disciplines related to biology/pharmacy for more than 10 years to high school and undergraduate students. In terms of education, he is a Pharmacist (University of ABC, Brazil, 2006). He earned a Master of Science degree (2009) and a PhD (2013) in Chemistry, both from the Federal University of ABC in Brazil. Furthermore, he completed his postdoctoral research at the University of São Paulo (2013-2015), and was a visiting researcher at the Eberhard-Karls Universität Tübingen in Germany (2022). To date, he has published more than 70 research and review articles in peer-reviewed scientific journals with a focus on Computer-Aided Drug Design (CADD) and 3 book chapters. Finally, he is a reviewer for more than 30 scientific periodicals withmore than 120 revisions completed.